Thompson Siegel & Walmsley’s Nu Skin NUS Stock Holding History

Thompson Siegel & Walmsley’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10	Closed	–	–	749
2019 Q4	$0	Buy	+10	New	+$408	﹤0.01%	852

Other funds holding NUS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Thompson Siegel & Walmsley's NUS Position: Q1 2020 in Review

Thompson Siegel & Walmsley sold out of Nu Skin (NUS) in Q1 2020, closing a stake of 10 shares.

Thompson Siegel & Walmsley first reported a position in NUS in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 199 funds tracked by Wall St. Rank hold NUS as of Q1 2020.

Thompson Siegel & Walmsley reported no remaining Nu Skin position as of Q1 2020 after selling out during the quarter.
Thompson Siegel & Walmsley sold 10 Nu Skin shares in Q1 2020.
Thompson Siegel & Walmsley first reported a position in Nu Skin in Q4 2019 and held it in 1 quarter.
Thompson Siegel & Walmsley's Nu Skin position peaked at $0 in Q4 2019.
199 funds tracked by Wall St. Rank held Nu Skin as of Q1 2020.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2020, filed 12 May 2020.